FOGSI Guideline Update on Cervical Cancer Screening:
Clinical Implications and the Role of Extended Genotyping
Wednesday, 28 October 2026
7:00PM–9:00PM (India)
Virtual Session
Join us on 28 October 2026
Join us online on Wed, 28 Oct 2026, for FOGSI Guideline Update on Cervical Cancer Screening: Clinical Implications and the Role of Extended Genotyping.
FOGSI has released a new position paper on cervical cancer screening. It puts extended HPV genotyping at the centre of how screening results are read and acted on. This webinar breaks down the key updates, explains why extended genotyping matters for patients, and uses case discussions with leading gynaecologic oncologists to show how the guideline works in daily practice.
Learning objectives:
- Understand the key updates in the new FOGSI position paper and what they mean for clinical practice
- Explain the role of extended HPV genotyping in risk stratification and patient care
- Apply the new guideline to real-world cases through expert-led discussion
Dr Bhaskar Pal
President, FOGSI
Dr Suvarna Khadilkar
Secretary General, FOGSI
Dr Bhagyalaxmi Nayak
President, AOGIN India
Dr Latha Balasubramani
Secretary, AOGIN India
Dr Aruna Nigam
President, ISCCP
Dr Bindiya Gupta
Secretary, ISCCP
Chairperson
Dr Priti Kumar
Lucknow
Convenors
Dr Saritha Shamsunder
Convenor
Professor of ObGyn & Gynecologic Oncology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi
Chairperson, FOGSI Gynecological Oncology Committee
Prof. (Dr) Neerja Bhatla
Co-Convenor
Professor Emeritus, NCI Jhajjar, AIIMS Delhi
Senior Consultant Gynecologist, Rejoice Hospital, New Delhi
Dr Jyoti Meena
Co-Convenor
Professor of Obstetrics & Gynecology, All India Institute of Medical Sciences, New Delhi
Panelists & Experts
Dr Jeff Andrews
Dr Leela Digumarti
Dr Priya Abraham
Dr Priya Ganeshkumar
Dr Dipanwita Banerjee
Register now to secure your attendance!
© $date.get('yyyy') Waters Corporation. All rights reserved. BD is a trademark of Becton, Dickinson and Company. Waters is a trademark of Waters Corporation or its affiliates. All other marks are the property of their respective owners.